The emerging age-pattern changes of patients with hepatocellular carcinoma in Korea

키워드

참고문헌 (21)

1. Young Eun Chon, "Hepatocellular carcinoma statistics in South Korea", Clinical and Molecular Hepatology, 27(3), pp.512~514 (2021), 대한간학회[DOI]
2. Ran Xu Zhu, "Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific Region", Gut and Liver, 10(3), pp.332~339 (2016), 거트앤리버 소화기연관학회협의회
3. 김보현, "Epidemiology of liver cancer in South Korea", Clinical and Molecular Hepatology, 24(1), pp.1~9 (2018), 대한간학회
4. "National Health and Nutrition Examination Survey (KNHANES) 2016"[URL]
5. Sun Woong Kim, "Toward a complete cure for chronic hepatitis B: Novel therapeutic targets for hepatitis B virus", Clinical and Molecular Hepatology, 28(1), pp.17~30 (2022), 대한간학회[DOI]
6. Young Eun Chon, "Hepatocellular carcinoma incidence is decreasing in Korea but increasing in the very elderly", Clinical and Molecular Hepatology, 29(1), pp.120~134 (2023), 대한간학회
7. Rahul Kumar, "Comparisons between non-alcoholic steatohepatitis and alcohol-related hepatocellular carcinoma", Clinical and Molecular Hepatology, 26(2), pp.196~208 (2020), 대한간학회[DOI]
8. 심주현, "Should you advocate for hepatocellular carcinoma surveillance in patients with alcohol-related liver disease or non-alcoholic fatty liver disease?", Clinical and Molecular Hepatology, 26(2), pp.183~184 (2020), 대한간학회[DOI]
9. Hwi Young Kim, "Intricate interpretation of etiology-specific outcome comparison in patients with hepatocellular carcinoma", Clinical and Molecular Hepatology, 26(2), pp.238~239 (2020), 대한간학회[DOI]
10. Ascha MS, "The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis", Hepatology, 51, pp.1972~1978 (2010)
11. Naoshi Nishida, "Metabolic disease as a risk of hepatocellular carcinoma", Clinical and Molecular Hepatology, 27(1), pp.87~90 (2021), 대한간학회[DOI]
12. Takuma Nakatsuka, "Development and prognosis of hepatocellular carcinoma in patients with diabetes", Clinical and Molecular Hepatology, 29(1), pp.51~64 (2023), 대한간학회
13. Stickel F, "Non-alcoholic fatty liver disease as a risk factor for hepatocellular carcinoma : mechanisms and implications", Gut, 59, pp.1303~1307 (2010)
14. Zhao L, "The gut microbiota and obesity : from correlation to causality", Nat Rev Microbiol, 11, pp.639~647 (2013)
15. Wong H, "The outcomes and safety of single-agent sorafenib in the treatment of elderly patients with advanced hepatocellular carcinoma(HCC)", Oncologist, 16, pp.1721~1728 (2011)
16. Tada T, "Safety and efficacy of lenvatinib in elderly patients with unresectable hepatocellular carcinoma : a multicenter analysis with propensity score matching", Hepatol Res, 50, pp.75~83 (2020)
17. Finn RS, "Atezolizumab plus bevacizumab in unresectable hepatocellular Carcinoma", N Engl J Med, 382, pp.1894~1905 (2020)
18. 김윤정, "Hepatocellular Carcinoma in the Elderly: Clinical Characteristics, Treatment, Survival Analysis in Korean Patients Older than 70 Years", Journal of Korean Medical Science, 27(10), pp.1147~1154 (2012), 대한의학회
19. Takuji Torimura, "Optimizing the management of intermediate-stage hepatocellular carcinoma: Current trends and prospects", Clinical and Molecular Hepatology, 27(2), pp.236~245 (2021), 대한간학회[DOI]
20. Tada T, "Safety and efficacy of atezolizumab plus bevacizumab in elderly patients with hepatocellular carcinoma : a multicenter analysis", Cancer Med, 11, pp.3796~3808 (2022)
21. Shigeo Shimose, "Impact of branched-chain amino acids and frailty on the management of lenvatinib-related fatigue in patients with hepatocellular carcinoma", Clinical and Molecular Hepatology, 27(4), pp.616~619 (2021), 대한간학회[DOI]

관련 논문AI추천